Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dare Bioscience (DARE) Shares Issued (2016 - 2023)

Dare Bioscience (DARE) has disclosed Shares Issued for 9 consecutive years, with $1.0 as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Shares Issued changed N/A year-over-year to $1.0, compared with a TTM value of $1.0 through Sep 2024, changed N/A, and an annual FY2023 reading of $1.3 million, changed N/A over the prior year.
  • Shares Issued was $1.0 for Q4 2023 at Dare Bioscience, down from $1.3 million in the prior quarter.
  • Across five years, Shares Issued topped out at $6.9 million in Q3 2021 and bottomed at -$6.5 million in Q4 2021.
  • Average Shares Issued over 4 years is $398389.0, with a median of $50400.0 recorded in 2021.
  • Peak annual rise in Shares Issued hit 5039900.0% in 2021, while the deepest fall reached 463.94% in 2021.
  • Year by year, Shares Issued stood at $1.8 million in 2020, then crashed by 463.94% to -$6.5 million in 2021, then surged by 98.15% to -$120149.0 in 2022, then soared by 100.0% to $1.0 in 2023.
  • Business Quant data shows Shares Issued for DARE at $1.0 in Q4 2023, $1.3 million in Q1 2023, and -$120149.0 in Q3 2022.